ESMO 2023 | Insights from PROSCA/BLADDR 2023: multidisciplinary discussions and educational components

Rob Jones, MD, PhD, The University of Glasgow, Glasgow, UK, highlights the value of the PROSCA/BLADDR congress. Emphasizing its unique qualities, he commends the congress for providing updates on recent clinically relevant data, fostering multidisciplinary discussions among medical professionals, and offering well-designed educational components. The interactive nature, featuring case-based discussions and audience voting, creates a platform for sharing uncertainties and learning global variations in medical practices. Prof. Jones also mentions the integration of case-based voting from the Mirrors of Medicine platform, showcasing a progressive approach to engaging expert and real-world opinions in the field of prostate and bladder cancer treatment. This interview took place at the Global Congress on Prostate and Bladder Cancer (PROSCA/BLADDR) 2023 in Malaga, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.